|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
956,580,000 |
Market
Cap: |
866.07(B) |
Last
Volume: |
3,374,911 |
Avg
Vol: |
3,268,697 |
52
Week Range: |
$434.7 - $909.04 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 720 |
Guru Rank Value : 1.4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
656 |
Total Buy Value |
$0 |
$0 |
$0 |
$199,549 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
1,520,577 |
2,391,327 |
3,771,329 |
6,318,238 |
Total Sell Value |
$1,284,658,855 |
$1,892,909,435 |
$2,147,483,647 |
$2,147,483,647 |
Total People Sold |
3 |
3 |
4 |
6 |
Total Sell Transactions |
18 |
31 |
50 |
93 |
End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Prendergast Franklyn G |
Director |
|
2016-11-30 |
4 |
A |
$76.64 |
$160,024 |
D/D |
2,088 |
66,904 |
|
- |
|
Runge Marschall S |
Director |
|
2016-11-30 |
4 |
A |
$76.64 |
$160,024 |
D/D |
2,088 |
7,187 |
|
- |
|
Luciano Juan R |
Director |
|
2016-11-30 |
4 |
A |
$76.64 |
$146,689 |
D/D |
1,914 |
1,914 |
|
- |
|
Marram Ellen R |
Director |
|
2016-11-30 |
4 |
A |
$76.64 |
$166,615 |
D/D |
2,174 |
49,801 |
|
- |
|
Hoover R David |
Director |
|
2016-11-30 |
4 |
A |
$76.64 |
$160,024 |
D/D |
2,088 |
33,504 |
|
- |
|
Jackson Jamere |
Director |
|
2016-11-30 |
4 |
A |
$76.64 |
$40,006 |
D/D |
522 |
522 |
|
- |
|
Fyrwald J Erik |
Director |
|
2016-11-30 |
4 |
A |
$76.64 |
$160,024 |
D/D |
2,088 |
54,439 |
|
- |
|
Alvarez Ralph |
Director |
|
2016-11-30 |
4 |
A |
$76.64 |
$169,911 |
D/D |
2,217 |
34,700 |
|
- |
|
Alvarez Ralph |
Director |
|
2016-10-31 |
4 |
A |
$78.53 |
$9,895 |
D/D |
126 |
32,483 |
|
- |
|
Marram Ellen R |
Director |
|
2016-10-31 |
4 |
A |
$78.53 |
$6,597 |
D/D |
84 |
47,627 |
|
- |
|
Crowe Maria A |
President, Mfg. Operations |
|
2016-10-05 |
4 |
AS |
$81.43 |
$149,424 |
D/D |
(1,835) |
92,484 |
|
- |
|
Crowe Maria A |
President, Mfg. Operations |
|
2016-10-04 |
4 |
AS |
$81.12 |
$33,503 |
D/D |
(413) |
94,319 |
|
- |
|
Crowe Maria A |
President, Mfg. Operations |
|
2016-10-03 |
4 |
D |
$80.26 |
$671,616 |
D/D |
(8,368) |
94,732 |
|
- |
|
Crowe Maria A |
President, Mfg. Operations |
|
2016-10-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,350 |
103,100 |
|
- |
|
Crowe Maria A |
President, Mfg. Operations |
|
2016-10-02 |
4 |
D |
$80.26 |
$151,210 |
D/D |
(1,884) |
84,750 |
|
- |
|
Crowe Maria A |
President, Mfg. Operations |
|
2016-10-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,130 |
86,634 |
|
- |
|
Walsh Fionnuala M |
SVP, Global Quality |
|
2016-10-02 |
4 |
D |
$80.26 |
$141,900 |
I/I |
(1,768) |
31,651 |
|
- |
|
Walsh Fionnuala M |
SVP, Global Quality |
|
2016-10-02 |
4 |
OE |
$0.00 |
$0 |
I/I |
3,760 |
33,419 |
|
- |
|
Barnes Melissa S |
Chief Eth/Cmpl Ofcr & SVP, ERM |
|
2016-10-02 |
4 |
D |
$80.26 |
$144,548 |
D/D |
(1,801) |
10,262 |
|
- |
|
Barnes Melissa S |
Chief Eth/Cmpl Ofcr & SVP, ERM |
|
2016-10-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,894 |
12,063 |
|
- |
|
Marram Ellen R |
Director |
|
2016-09-30 |
4 |
A |
$79.16 |
$6,570 |
D/D |
83 |
47,543 |
|
- |
|
Alvarez Ralph |
Director |
|
2016-09-30 |
4 |
A |
$79.16 |
$9,895 |
D/D |
125 |
32,357 |
|
- |
|
Alvarez Ralph |
Director |
|
2016-08-31 |
4 |
A |
$80.26 |
$9,952 |
D/D |
124 |
32,026 |
|
- |
|
Marram Ellen R |
Director |
|
2016-08-31 |
4 |
A |
$80.26 |
$6,581 |
D/D |
82 |
47,163 |
|
- |
|
Simmons Jeffrey N |
SVP&Pres. Elanco Animal Health |
|
2016-08-31 |
4 |
D |
$77.77 |
$235,876 |
D/D |
(3,033) |
117,513 |
|
- |
|
1436 Records found
|
|
Page 44 of 58 |
|
|